These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 35225222

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
    Khan F, Brady S, Kuttikat A.
    Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders.
    Woolley M, Stebbings S, Highton J.
    Intern Med J; 2018 Jan; 48(1):32-36. PubMed ID: 28782163
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase.
    Essers D, Schäublin M, Kullak-Ublick GA, Weiler S.
    Eur J Clin Pharmacol; 2019 Mar; 75(3):409-416. PubMed ID: 30430215
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.
    Khoo T, Chinoy H.
    Autoimmun Rev; 2023 Dec; 22(12):103468. PubMed ID: 37884200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL.
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [Abstract] [Full Text] [Related]

  • 16. [Two cases of statin-induced immune-mediated necrotizing myopathy].
    Safi T, Wagner H.
    Lakartidningen; 2021 Dec 01; 118():. PubMed ID: 34861042
    [Abstract] [Full Text] [Related]

  • 17. Statin-induced, immune-mediated necrotising myopathy triggered by malignancy successfully treated with immunosuppression.
    Abouelazm A, Philops K, Amine A, Golam Y.
    Clin Med (Lond); 2024 May 01; 24(3):100217. PubMed ID: 38710328
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
    Hinschberger O, Lohmann C, Lannes B, Martzolff L, Vo BD, Jaeger-Bizet F, Ciobanu E, Kieffer P.
    Rev Med Interne; 2014 Aug 01; 35(8):546-9. PubMed ID: 23910221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.